Abstract
The main purpose of this study was to evaluate the association between reduction in XRCC2 gene and involvement of lymph node metastasis in breast cancer. In first part of the study, meta-analysis of 14 published XRCC2 studies was performed to define the role of XRCC2 gene as diagnostic marker and in second part of the study XRCC2 gene expression was observed using real time PCR in study cohort of 100 females (50 breast cancer patients and 50 controls). A statistically significant down regulation of XRCC2 (p < 0.04) and up-regulation of ki-67 (p < 0.05) was observed in breast cancer tissues compared to non-cancerous healthy tissues. In order to explore gene–gene and gene-clinicopathological parameters relationship Spearmen correlation was performed. We observed a significantly negative correlation between XRCC2 and Ki-67 expression (r = −0.376**, p < 0.01). In case of gene-clinicopathological parameters relationship, we observed a significant correlation between XRCC2 expression and lymph node status (r = −0.521***, p < 0.002) and metastatic status (r = −0.303*, p < 0.04) of breast cancer patients. Our data suggests that deregulation of XRCC2 in breast cancer has the potential to predict lymph node metastasis and may serve as a therapeutic target for breast cancer patients at risk of metastasis.
References
Jiao L, Hassan MM, Bondy ML, Wolff RA, Evans DB, Abbruzzese JL, Li D (2007) XRCC2 and XRCC3 gene polymorphism and risk of pancreatic cancer. Am J Gatroenterol 103:360–367
Curtin K, Lin WY, George R, Katory M, Shorto J, Cannon-Albright LA, Smith G, Bishop DT, Cox A, Camp NJ, Genetic Variants inXRCC2 (2009) New insights into colorectal cancer tumorigenesis. Cancer Epidemiol Biomarkers Prev 18:2476–2484
Mohindra A, Hays LE, Phillips EN, Preston BD, Helleday T, Meuth M (2002) Defects in homologous recombination repair in mismatch-repair deficient tumour cell lines. Hum Mol Genet 11:2189–2200
Rodrigue A, Lafrance M, Gauthier MC, McDonald D, Hendzel M, West SC, Jasin M, Masson JY (2006) Interplay between human DNA repair proteins at a unique double-strand break in vivo. EMBO J 25:222–231
Phillips ER, McKinnon PJ (2007) DNA double-strand break repair and development. Oncogene 26:7799–7808
Paul O, Wilson C, Townsend S, Thacker J (2001) XRCC2 Is a nuclear RAD51-like protein required for damage-dependent RAD51 focus formation without the need for ATP binding. J Biol Chem 276(25):22148–22153
Simone B, Tuimala J, Christine B, Pierre D, Alain S, Ari H (2004) DNA repair gene XRCC2 and XRCC3 polymorphisms and susceptibility to cancers of the upper aerodigestive tract. Int J Cancer 112:901–904
Park SJ, Byung B, Keun HN, Yoo Y (2008) Aetiology of cancer in Asia. APJCP 9:371–380
Cathryn ET, Karen GS, Caroline JR, Mark AH, John T (2010) The importance of XRCC2 in RAD51-related DNA damage repair. DNA Repair Cancer Res 9:517–525
Mahjabeen I, Chen Z, Zhou X, Kayani MA (2012) Decreased mRNA expression levels of base excision repair (BER) pathway genes is associated with enhanced Ki-67 expression in HNSCC. Med Oncol 29:3620–3625
Gong P, Wang Y, Liu G, Zhang J, Wang Z (2013) New insight into Ki67 expression at the invasive front in breast cancer. PLoS One 1:e54912
Varga Z, Diebold J, Dommann-Scherrer C, Frick H, Kaup D, Noske A, Obermann E, Ohlschlegel C, Padberg B, Rakozy C, Oliver SS, Schobinger-Clemen S, Schreiber-Facklam H, Singer G, Tapia C, Wagner U, Mastropasqua MG, Viale G, Lehr H (2012) How reliable is Ki-67 immunohistochemistry in grade 2 breast carcinomas? A QA study of the swiss working group of breast- and gynecopathologists. PLoS One 7:e37379
Bonanni B, Puntoni M, Cazzaniga M, Pruneri G, Serrano D, Guerrieri-Gonzaga A, Gennari A, Trabacca MS, Galimberti V, Veronesi P, Johansson H, Aristarco V, Bassi F, Luini A, Lazzeroni M, Varricchio C, Viale G, Bruzzi P, Decensi A (2012) Dual effect of metformin on breast cancer proliferation in a randomized presurgical trial. J Clin Oncol 30:2593–2600
Sa´nchez-Rovira P, Anto´n A, Barnadas A, Velasco A, Lomas M, Rodríguez-Pinilla M, Ramírez JL, Ramírez C, Ríos MJ, Castellá E, García-Andrade C, San Antonio B, Carrasco E, Palacios JL (2012) Classical markers like ER and ki-67, but also survivin and pERK, could be involved in the pathological response to gemcitabine, adriamycin and paclitaxel (GAT) in locally advanced breast cancer patients: results from the GEICAM 2002-01 phase II study. Clin Transl Oncol 14:430–436
Benhamou S, Tuimala J, Bouchardy C, Dayer P, Sarasin A, Hirvonen A (2004) DNA repair gene XRCC2 and XRCC3 polymorphisms and susceptibility to cancers of the upper aerodigestive tract. Int J Cancer 112(5):901–904
Saviozzi S, Ceppi P, Novello S (2009) Non-small cell lung cancer exhibits transcript recombination and DNA replication pathways overexpression of genes associated with homologous. Cancer Res 6:3390–3396
Chang-Claude J, Ambrosone CB, Lilla C, Kropp S, Helmbold I, von Fournier D, Haase W, Sautter-Bihl ML, Wenz F, Schmezer P, Popanda O (2009) Genetic polymorphisms in DNA repair and damage response genes and late normal tissue complications of radiotherapy for breast cancer. Br J Cancer 100:1680–1686
Bastos HN, Antao MR, Silva SN, Azevedo AP, Manita I, Teixeira V, Pina JE, Gil OM, Ferreira TC, Limbert E, Rueff J, Gaspar JF (2009) Association of polymorphisms in genes of the homologous recombination DNA repair pathway and thyroidcancer risk. Thyroid 19(10):1067–1075
Silva SN, Tomar M, Paulo C, Gomes BC, Azevedo AP, Teixeira V, Pina JE, Rueff J, Gaspar JF (2010) Breast cancer risk and common single nucleotide polymorphisms in homologous recombination DNA repair pathway genes XRCC2, XRCC3, NBS1 and RAD51. Cancer Epidemiol 34:85–92
Romanowicz H, Smolarz B, Baszczyński J, Zadrożny M, Kulig A (2010) Genetics polymorphism in DNA repair genes by base excision repair pathway (XRCC1) and association between polymorphisms of the RAD51-G135C, XRCC2-Arg188His and homologous recombination (XRCC2 and RAD51) and the risk of breast carcinoma in the Polish population. Pol J Pathol 61:206–212
Krupa R, Sliwinski T, Wisniewska-Jarosinska M, Chojnacki J, Wasylecka M, Dziki L, Morawiec J, Blasiak J (2011) Polymorphisms in RAD51, XRCC2 and XRCC3 genes of the homologous recombination repair in colorectal cancer: a case control study. Mol Biol Rep 38:2849–2854
Yin M, Liao Z, Huang YJ, Liu Z, Yuan X, Gomez D, Wang LE, Wei Q (2011) Polymorphisms of homologous recombination genes and clinical outcomes of non small cell lung cancer patients treated with definitive radio therapy. PLoS One 6:e20055
Romanowicz-Makowska H, Smolarz B, Zadrozny M, Westfal B, Baszczynski J, Polac I, Sporny S (2011) Single nucleotide polymorphisms in the homologous recombination repair genes and breast cancer risk in Polish women. Tohoku J Exp Med 224:201–208
Romanowicz-Makowska H, Smolarz B, Zadrozny M, Westfa B, Baszczyński J, Kokołaszwili G, Burzyfiski M, Połać I, Sporny S (2012) The XRCC3-Thr241Met genes and clinico-pathologic features in breast cancer in Poland. Eur J Gynaecol Oncol 33:145–150
Romanowicz-Makowska H, Smolarz B, Houli A, Szyłło K (2011) Single nucleotide polymorphism in DNA base excision repair genes XRCC1 and hOGG1 and the risk ofendometrial carcinoma in the Polish population. Pol J Pathol 62:89–94
Butkiewicz D, Drosik A, Suwiński R, Krześniak M, Rusin M, Kosarewicz A, Rachtan J, Matuszczyk I, Gawkowska-Suwińska M (2012) Influence of DNA repair gene polymorphisms on prognosis in inoperable non-small cell lung cancer patients treated with radiotherapy and platinum-based chemotherapy. Int J Cancer 131:E1100–E1108
Romanowicz-Makowska H, Smolarz B, Gajęcka M, Kiwerska K, Rydzanicz M, Kaczmarczyk D, Olszewski J, Szyfter K, Błasiak J, Morawiec-Sztandera A (2012) Polymorphism of the DNA repair genes RAD51 and XRCC2 in smoking- and drinking-related laryngeal cancer in a Polish population. Arch Med Sci 8(6):1065–1075
Fayaz S, Karimmirza M, Tanhaei S, Fathi M, Torbati PM, Fard-Esfahani P (2013) Increased risk of differentiated thyroid carcinoma with combined effects of homologous recombination repair gene polymorphisms in an Iranian population. APJCP 14(11):6727–6731
Mohamed FZ, Hussien YM, AlBakry MM, Mohamed RH, Said NM (2013) Role of DNA repair and cell cycle control genes in ovarian cancer susceptibility. Mol Biol Rep 40:3757–3768
Petruzzelli GJ (2000) The biology of tumor invasion, angiogenesis and lymph node metastasis. ORL J Otorhinolaryngol Relat Spec 62(4):178–185
Kaisa R, Luoto AX, Meng ARW (2010) Genes that Control DNA Double-Strand Break Repair Tumor Cell Kill by c-MYC Depletion: role of MYC-Regulated. Can Res 70:8748–8759
Zheng Z, Wooi LN, Zhang X (2012) RNAi-Mediated Targeting of Noncoding and Coding Sequences in DNA Repair Gene Messages Efficiently Radiosensitizes Human Tumor Cells. Cancer Res 72(5):3254–3258
Margeli M, Cirauqui B, Castella E, Tapia G, Costa C, Gimenez-Capitan A, Barnadas A, Ronco MS, Benlloch S, Taron M, Rosell R (2010) The prognostic value of BRCA1 mRNA expression levels following neoadjuvant chemotherapy in breast cancer. PLoS One 5(3):1–9
Yuanming L, Lineng Z, Baorong S, Junjie P, Sanjun C (2013) BRCA1and ERCC1mRNA levels are associated with lymph node metastasis in Chinese patients with colorectal cancer. BMC Cancer 13:103–111
Faratzis G, Tsiambas E, Rapidis AD, Machaira A, Xiromeritis K, Patsouris E (2009) VEGF and ki 67 expression in squamous cell carcinoma of the tongue: an immunohistochemical and computerized image analysis study. Oral Oncol 45:584–588
Kim SJ, Shin HJ, Jung K, Baek S, Shin BK, Choi J, Kim BS, Shin SW, Kim YH, Kim JS, Oosterwijk E (2007) Prognostic value of carbonic anhydrase IX and Ki-67 expression in squamous cell carcinoma of the tongue. Jpn J Clin Oncol 37:812–819
Liu X, Wang A, Muzio LL, Kolokythas A, Sheng S, Rubin C, Ye H, Shi F, Yu T, Crowe DL, Zhou X (2010) Deregulation of manganese superoxide dismutase (SOD2) expression and lymph node metastasis in tongue squamous cell carcinoma. BMC Cancer 10:365
Inwald EC, Klinkhammer-Schalke M, Klinkhammer-Schalke F, Zeman F, Koller M, Gerstenhauer M, Ortmann O (2013) Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry. Breast Cancer Res Treat 139:539
Acknowledgments
All authors wish to acknowledge the patients and control individuals who contributed to this research work. We are also thankful to hospital staff (Nuclear Oncology and Radiotherapy Institute Islamabad (NORI) and Military Hospital Rawalpindi (MH) Pakistan, for their help and cooperation.
Conflict of interest
Authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Nabiha Bashir and Syeda Sana have contributed equally to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Bashir, N., Sana, S., Mahjabeen, I. et al. Association of reduced XRCC2 expression with lymph node metastasis in breast cancer tissues. Familial Cancer 13, 611–617 (2014). https://doi.org/10.1007/s10689-014-9745-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10689-014-9745-0